Schedule 13G ownership disclosure
APTEVO THERAPEUTICS INC
Common Stock · CUSIP: 03835L504
Event date: 2025-06-18
- Filing-level shares
- 285,000.00
- Percent of class
- 9.95%
- L1 Capital Global Opportunities Master Fund, Ltd.
Shares: 285,000.00 · Class: 9.95%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001079973-25-001053
- Form type
- SCHEDULE 13G
- Filer
- Aptevo Therapeutics Inc.
- CIK
- CIK 1671584
- Filed
- Jun 23, 2025
- Reporting period
- Jun 18, 2025
- Description
- Schedule 13G beneficial ownership